quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:23:20·28d
SECFiling
SpyGlass Pharma Inc. logo

SEC Form 10-K filed by SpyGlass Pharma Inc.

SGP· SpyGlass Pharma Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • SGP
    SpyGlass Pharma Inc.
    Health Care

Recent analyst ratings

  • Mar 10UpdateH.C. Wainwright$37.00
  • Mar 3UpdateStifel$42.00
  • Mar 3UpdateJefferies$62.00
  • Mar 3UpdateCitigroup$42.00
  • Mar 3UpdateLeerink Partners$42.00

Related

  • SEC28d
    SpyGlass Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR28d
    SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
  • ANALYST44d
    H.C. Wainwright initiated coverage on SpyGlass Pharma with a new price target
  • SEC45d
    SpyGlass Pharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR45d
    SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
  • PR50d
    SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
  • ANALYST51d
    Stifel initiated coverage on SpyGlass Pharma with a new price target
  • ANALYST51d
    Citigroup initiated coverage on SpyGlass Pharma with a new price target
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022